CC SC islets (2.5k IEQ: 4/5; MRT, 29 days; 2k IEQ: 4/5; MRT, 39 days) showed a trend toward improved diabetes reversal rate compared with unencapsulated SC islets at both doses analyzed, although not significantly ( Figure 4 G; 2.5k IEQ p = 0.12; 2k IEQ p = 0.60).
← all excerpts
Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes.
1
—
—